Analyst Recommendations

33.86 1.59(4.93%)10/04/2024
Tarsus Pharmaceuticals Inc (TARS)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy3
Outperform3
Overweight2
Neutral1

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades